NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

PODD

Insulet Corporation

Jun 20 • 04:00PM ET

303.15

Dollar change +1.36
Percentage change 0.45	%

Healthcare • Medical Devices • USA • NASD

Peers: DXCM JNJ ABT MDT EW SYK TNDM BSX BAX LIVN

| Held by: VTI VOO VB VO SPY IVV VUG VBK XLV RSP

Scroll to Statements

Index	S&P 500	P/E	54.55	EPS (ttm)	5.56	Insider Own	0.51%	Shs Outstand	70.36M	Perf Week	-0.15%
Market Cap	21.33B	Forward P/E	55.83	EPS next Y	5.43	Insider Trans	-8.15%	Shs Float	70.02M	Perf Month	-7.43%
Enterprise Value	21.75B	PEG	1.97	EPS next Q	0.92	Inst Own	102.04%	Short Float	2.72%	Perf Quarter	14.23%
Income	402.20M	P/S	9.70	EPS this Y	34.34%	Inst Trans	0.27%	Short Ratio	2.21	Perf Half Y	14.18%
Sales	2.20B	P/B	16.03	EPS next Y	24.76%	ROA	13.10%	Short Interest	1.90M	Perf YTD	16.12%
Book/sh	18.91	P/C	16.63	EPS next 5Y	27.69%	ROE	37.92%	52W Range	173.00 - 329.33	Perf Year	52.80%
Cash/sh	18.23	P/FCF	73.21	EPS past 3/5Y	186.88% 98.82%	ROIC	13.67%	52W High	-7.95%	Perf 3Y	47.48%
Dividend Est.	-	EV/EBITDA	50.08	Sales past 3/5Y	23.54% 22.92%	Gross Margin	71.14%	52W Low	75.23%	Perf 5Y	64.04%
Dividend TTM	-	EV/Sales	9.89	EPS Y/Y TTM	71.25%	Oper. Margin	15.50%	Volatility	0.78% 1.04%	Perf 10Y	913.54%
Dividend Ex-Date	-	Quick Ratio	3.59	Sales Y/Y TTM	23.49%	Profit Margin	18.29%	RSI (14)	47.89	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	4.43	EPS Q/Q	-31.57%	SMA20	-3.28%	Beta	1.38	Target Price	342.30
Payout	0.00%	Debt/Eq	1.27	Sales Q/Q	28.82%	SMA50	4.57%	Rel Volume	1.79	Prev Close	301.79
Employees	3900	LT Debt/Eq	1.21	Earnings	May 08 AMC	SMA200	14.45%	Avg Volume	860.14K	Price	303.15
IPO	May 15, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	29.11% 4.73%	Trades		Volume	1,538,208	Change	0.45%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	Truist	Buy	$365
May-30-25	Initiated	Goldman	Buy	$380
May-13-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$350
Apr-29-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Mar-06-25	Initiated	RBC Capital Mkts	Outperform	$340
Nov-06-24	Initiated	Bernstein	Outperform	$300
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265
Aug-21-23	Downgrade	Robert W. Baird	Outperform → Neutral	$320 → $219
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$343
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$235 → $340
Oct-18-22	Initiated	Barclays	Equal Weight	$238
Oct-12-22	Initiated	Jefferies	Hold	$260
Jul-11-22	Downgrade	Citigroup	Buy → Neutral	$310 → $250
Mar-02-22	Resumed	BofA Securities	Buy	$300

Show Previous Ratings

Jun-19-25 06:00AM	Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions (Business Wire)
Jun-17-25 09:35AM	Cisco upgraded, CoreWeave downgraded: Wall Streets top analyst calls (TipRanks)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-11-25 09:51AM	Here's Why You Should Retain PODD Stock in Your Portfolio Now (Zacks)
Jun-10-25 08:30AM	Insulets Omnipod 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users (Business Wire)
04:36AM	Loading…
04:36AM	PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption (StockStory)
Jun-09-25 07:29AM	3 Medical Technology Stocks Outperforming in 2025 (MarketBeat)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
Jun-05-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
12:01AM	3 Reasons Investors Love Insulet (PODD) (StockStory)
Jun-04-25 11:33PM	Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks (StockStory)
09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Jun-03-25 11:30AM	S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF (Zacks)
Jun-02-25 03:18PM	Solventum Stock Earns RS Rating Upgrade (Investor's Business Daily)
May-30-25 10:17AM	Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy (Investing.com)
08:30AM	Loading…
May-26-25 08:30AM	Insulet Gains 78.5% in a Year: What's Driving the Stock? (Zacks)
May-23-25 06:01AM	Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Business Wire)
May-22-25 09:36AM	Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies (Zacks)
May-21-25 11:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
May-16-25 09:50AM	Here's Why Insulet (PODD) is a Strong Momentum Stock (Zacks)
05:51AM	Dexcom CEO says CGMs fit MAHA agenda very nicely; Tandem preps for new products (MedTech Dive)
May-15-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
May-14-25 12:45PM	Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today (Insider Monkey)
08:45AM	Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer (MarketBeat)
07:20AM	Outlier Money Flows Lift Insulet (FX Empire)
May-13-25 06:00AM	Insulet Announces Publication of 2024 Sustainability Report (Business Wire)
May-12-25 09:10AM	Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised (Zacks)
May-10-25 11:47AM	S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points (Investor's Business Daily)
May-09-25 08:41PM	Analyst Report: Insulet Corporation (Morningstar Research) +20.88%
05:49PM	S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks (Investopedia)
05:49PM	Loading…
05:49PM	S&P 500 Gains & Losses Today: Index Pulls Back Early Gains Amid Anticipation of Trade Talks (Investopedia)
04:02PM	Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops (Investor's Business Daily)
02:37PM	Insulet Stock Soars to Lead S&P 500 Gainers Friday (Investopedia)
02:16PM	Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops (Yahoo Finance Video)
11:57AM	Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More (Investopedia)
11:29AM	New Insulet CEO Ashley McEvoy sets priorities (MedTech Dive)
10:11AM	Insulet Stock Is the Top S&P 500 Performer Today. Heres Why. (Barrons.com)
08:21AM	Q1 2025 Insulet Corp Earnings Call (Thomson Reuters StreetEvents)
03:39AM	Insulet Corp (PODD) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion (GuruFocus.com)
May-08-25 07:01PM	Analyst Report: Insulet Corporation (Morningstar Research)
05:30PM	Insulet (PODD) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates (Zacks)
04:11PM	Insulet Makes A Bullish Post-Earnings Move With A Beat-And-Raise (Investor's Business Daily)
04:11PM	Insulet Jumps After Beating Quarterly Forecasts, Raising 2025 Expectations (Investor's Business Daily)
04:10PM	Insulet: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1) (Business Wire)
May-07-25 05:20PM	Insulet Q1 2025 Earnings Preview (Seeking Alpha)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-05-25 09:15AM	Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
12:33AM	1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About (StockStory)
Apr-29-25 09:30PM	Franklin Convertible Securities Fund Q1 2025 Commentary (Seeking Alpha)
Apr-28-25 10:00AM	Insulet Names New CEO, Expects to Top Revenue Projections (Investopedia)
09:06AM	Ashley McEvoy named Insulet CEO (MedTech Dive)
09:04AM	1 Healthcare Stock Worth Your Attention and 2 to Turn Down (StockStory)
06:00AM	Insulet Appoints Ashley McEvoy President and CEO (Business Wire)
Apr-17-25 08:52AM	4 Medical Product Stocks to Buy From a Challenging Industry (Zacks)
Apr-14-25 12:18PM	International Growth Drives GMED Stock Amid Fierce Competition (Zacks)
08:24AM	Bruker Stock May Benefit Following Its Investment in Ridom GmbH (Zacks)
Apr-13-25 08:38AM	Oakmark Bond Fund Q1 2025 Commentary (Seeking Alpha)
Apr-11-25 10:01AM	Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? (Zacks)
Apr-10-25 05:17AM	Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength? (Zacks) -5.01%
Apr-09-25 08:09AM	5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout (Zacks) +7.16%
Apr-08-25 11:55AM	Oakmark Fixed Income Market Q1 2025 Commentary (Seeking Alpha)
10:02AM	PODD Stock Benefits From the Launch of Omnipod 5 in Canada (Zacks)
Apr-07-25 01:34PM	This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength (Investor's Business Daily)
07:07AM	Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above (PR Newswire)
Apr-03-25 02:25PM	Analyst Report: Insulet Corporation (Morningstar Research)
06:00AM	Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 (Business Wire)
Mar-31-25 09:30AM	DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes (Zacks)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-27-25 10:50AM	Columbia Select Large Cap Growth Fund Q4 2024 Commentary (SeekingAlpha)
05:14AM	3 Reasons Investors Love Insulet (PODD) (StockStory)
Mar-24-25 08:09AM	Insulet Gains 62.9% in a Year: What's Driving the Stock? (Zacks)
Mar-21-25 12:36PM	PODD Stock Gains Following the Launch of Omnipod 5 in Australia (Zacks)
08:30AM	Artisan International Small-Mid Fund Q4 2024 Commentary (SeekingAlpha)
08:19AM	DGX Stock Set to Benefit From New Google Cloud Partnership (Zacks)
05:06AM	Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers (StockStory)
Mar-20-25 12:41PM	PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5 (Zacks)
08:23AM	LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:54AM	Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data (MedTech Dive)
Mar-19-25 04:01PM	Insulets RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections (Business Wire)
11:03AM	3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan (Zacks)
Mar-18-25 04:32PM	Insulet Announces Pricing of Senior Notes Due 2033 (Business Wire)
01:51PM	Insulet Corporation (PODD): Among the Best Diabetes Stocks to Buy According to Billionaires (Insider Monkey)
10:35AM	Insulet Chief Technology Officer Mark Field leaves (MedTech Dive)
07:35AM	Insulet Announces Proposed Financing Transactions (Business Wire)
06:05AM	Insulet Expands Omnipod 5 to Four More International Markets (Business Wire)
06:00AM	From Injections to Innovation Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod 5 in Adults and Children with Type 1 Diabetes (Business Wire)
Mar-11-25 06:00AM	Insulet to Host Investor Day on June 5, 2025 (Business Wire)
Mar-07-25 09:41AM	Robinhood initiated, MongoDB downgraded: Wall Streets top analyst calls (TipRanks)
Feb-27-25 09:23PM	Analyst Report: Insulet Corporation (Morningstar Research)
06:49AM	Tandems insulin pump tech wins FDA nod for Type 2 diabetes (MedTech Dive)
04:05AM	Reflecting On Patient Monitoring Stocks Q4 Earnings: DexCom (NASDAQ:DXCM) (StockStory)
Feb-26-25 08:04AM	Insulet Sales Keep Rising (FX Empire)
Feb-25-25 02:52PM	Medtronic Stock Gets IBD Rating Lift (Investor's Business Daily) -5.93%
Feb-21-25 01:28PM	Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst (Benzinga)
10:45AM	Analyst Report: Insulet Corporation (Morningstar Research)
02:15AM	Insulet Corp (PODD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion ... (GuruFocus.com)
Feb-20-25 05:30PM	Compared to Estimates, Insulet (PODD) Q4 Earnings: A Look at Key Metrics (Zacks)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singh Prem	SVP, Global Operations	Jun 13 '25	Option Exercise	166.62	1,257	209,441	6,470	Jun 16 04:18 PM
Singh Prem	SVP, Global Operations	Jun 13 '25	Sale	300.05	2,327	698,216	4,143	Jun 16 04:18 PM
Manea Dan	SVP, Chief HR Officer	Jun 13 '25	Sale	300.05	1,300	390,065	9,090	Jun 16 04:16 PM
Singh Prem	Officer	Jun 13 '25	Proposed Sale	300.05	2,327	698,216		Jun 13 10:15 AM
Manea Dan	Officer	Jun 13 '25	Proposed Sale	300.05	1,300	390,065		Jun 13 09:45 AM
BORIO LUCIANA	Director	Jun 09 '25	Sale	305.73	481	147,056	3,087	Jun 10 04:17 PM
BORIO LUCIANA	Director	Jun 09 '25	Proposed Sale	305.72	481	147,054		Jun 09 01:08 PM
Hollingshead James	Former Officer	May 16 '25	Proposed Sale	323.10	15,605	5,041,964		May 16 04:40 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Option Exercise	95.43	5,278	503,680	28,458	May 15 04:25 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Sale	318.47	5,278	1,680,885	23,180	May 15 04:25 PM
Hopfield Jessica	Director	May 13 '25	Option Exercise	28.87	5,235	151,134	32,152	May 14 04:15 PM
Hopfield Jessica	Director	May 13 '25	Sale	317.54	5,235	1,662,322	26,917	May 14 04:15 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Option Exercise	92.11	3,001	276,422	23,907	May 14 04:08 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Sale	320.00	3,001	960,320	20,906	May 14 04:08 PM
Kapples John W.	Officer	May 14 '25	Proposed Sale	318.47	5,278	1,680,901		May 14 12:32 PM
Field Mark N	Former Officer	May 13 '25	Proposed Sale	321.31	2,457	789,459		May 13 01:44 PM
Benjamin Eric	Officer	May 13 '25	Proposed Sale	320.00	3,001	960,320		May 13 12:51 PM
Hopfield Jessica	Director	May 13 '25	Proposed Sale	317.54	5,235	1,662,322		May 13 10:19 AM
Frederick Wayne A.I.	Director	Mar 25 '25	Sale	275.00	1,825	501,875	3,231	Mar 26 04:22 PM
Frederick Wayne A.I.	Director	Mar 25 '25	Proposed Sale	275.00	1,825	501,875		Mar 25 10:30 AM
Benjamin Eric	EVP, CPXO	Mar 03 '25	Option Exercise	56.52	5,146	290,873	20,906	Mar 04 04:09 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Option Exercise	65.00	5,075	329,898	23,777	Jan 22 04:10 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Sale	280.00	12,394	3,470,320	11,383	Jan 22 04:10 PM
Benjamin Eric	Officer	Jan 21 '25	Proposed Sale	280.00	12,394	3,470,320		Jan 21 10:56 AM
Benjamin Eric	EVP, CPXPO	Dec 16 '24	Sale	267.60	4,362	1,167,271	18,702	Dec 17 04:14 PM
Benjamin Eric	Officer	Dec 16 '24	Proposed Sale	267.60	4,362	1,167,271		Dec 16 10:38 AM
Budden Lauren	Group VP, CAO and Controller	Dec 10 '24	Sale	275.62	915	252,192	5,733	Dec 11 04:00 PM
Budden Lauren	Officer	Dec 10 '24	Proposed Sale	275.62	915	252,194		Dec 10 05:18 PM
BORIO LUCIANA	Director	Nov 12 '24	Sale	274.80	508	139,598	2,790	Nov 13 04:01 PM
BORIO LUCIANA	Director	Nov 12 '24	Proposed Sale	274.81	508	139,602		Nov 12 04:01 PM
Hopfield Jessica	Director	Sep 11 '24	Option Exercise	29.87	7,628	227,848	34,545	Sep 12 04:07 PM
Hopfield Jessica	Director	Sep 11 '24	Sale	225.26	7,628	1,718,283	26,917	Sep 12 04:07 PM
Scannell Timothy J	Director	Sep 10 '24	Sale	225.84	5,000	1,129,200	30,586	Sep 11 04:13 PM
Hopfield Jessica	Director	Sep 11 '24	Proposed Sale	225.26	7,628	1,718,283		Sep 11 03:40 PM
Field Mark N	SVP & Chief Technology Officer	Sep 09 '24	Sale	220.87	1,383	305,463	9,761	Sep 10 04:16 PM
Budden Lauren	Group VP, CAO and Controller	Sep 09 '24	Sale	221.41	1,506	333,443	6,609	Sep 10 04:15 PM
Scannell Timothy J	Director	Sep 10 '24	Proposed Sale	225.84	5,000	1,129,210		Sep 10 02:27 PM
Field Mark N	Officer	Sep 09 '24	Proposed Sale	220.87	1,383	305,465		Sep 09 04:50 PM
Budden Lauren	Officer	Sep 09 '24	Proposed Sale	221.41	1,506	333,436		Sep 09 01:20 PM
Singh Prem	SVP, Global Operations	Aug 30 '24	Sale	202.27	1,824	368,940	3,656	Sep 03 04:30 PM
Singh Prem	Officer	Aug 30 '24	Proposed Sale	202.27	1,824	368,938		Aug 30 03:22 PM
Chadwick Ana Maria	EVP, CFO & Treasurer	Aug 29 '24	Buy	206.00	100	20,600	13,314	Aug 29 04:17 PM
Field Mark N	SVP & Chief Technology Officer	Aug 28 '24	Sale	203.00	1,387	281,561	11,347	Aug 29 04:14 PM
Field Mark N	Officer	Aug 28 '24	Proposed Sale	203.00	1,387	281,561		Aug 28 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PODD

Insulet Corporation

Upgrade your FINVIZ experience